NCT00160680View on ClinicalTrials.gov

ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 1, 2005

Primary Completion Date

June 1, 2006

Study Completion Date

June 1, 2006

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Levocetirizine

"* Pharmaceutical form: Tablet~* Concentration: 5 mg~* Route of administration: Oral use"

Trial Locations (1)

Unknown

Genova

All Listed Sponsors
lead

UCB S.A. - Pharma Sector

INDUSTRY

NCT00160680 - ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) | Biotech Hunter | Biotech Hunter